60

Zhende Medical Co LtdSHG 603301 Stock Report

Last reporting period 30 Sep, 2023

Updated 21 Oct, 2024

Last price

Market cap $B

0.787

Micro

Exchange

XSHG - Shanghai Stock Exchange

603301.SS Stock Analysis

60

Neutral

Based on Eyestock quantitative analysis, 603301.SS`s fundamental data and valuation indicate an investment grade of Neutral at the current time.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

78/100

Moderate score

Upside

To determine whether the current price is a reasonable to buy a stock, we compare it to our estimate of fair value. The more undervalued a stock is, the higher the upside.

32.0 %

Undervalued

Market cap $B

0.787

Dividend yield

5.85 %

Shares outstanding

264.35 B

Zhende Medical Co., Ltd. engages in the production, research, development, and sale of medical dressing. The company is headquartered in Shaoxing, Zhejiang and currently employs 8,027 full-time employees. The company went IPO on 2018-04-12. The Company’s main products include modern wound dressings, surgical control products, traditional wound care products and pressure treatment and fixation products. The firm mainly distributes its products in domestic market and to overseas markets.

View Section: Eyestock Rating